Application Note: Streamlined workflows for N-glycan analysis of biotherapeutics
1 July 2021

In this application note, Agilent Technologies describes the preparation and analysis of released N-glycans from biotherapeutic glycoproteins using two labels, InstantPC and 2-aminobenzamide (2-AB). N-glycan analysis is vital to the development and production of biotherapeutics, as glycosylation can influence the therapeutic function of the final drug product.